Abstract:Background: Yindan Xinnaotong soft capsule (YDXNT) is a clinically effective herbal prescription used for the treatment of cardiovascular and cerebrovascular diseases. Since Chinese medicines (CMs) exert their effects via a "multiple-components and multiple-targets" mode, discovery of the active compounds with interactive effects may contribute to reveal their mechanisms of action. Purpose: This study aimed to establish an image-based fingerprint-efficacy screening strategy to identify active compounds with interaction effects from CM prescription, using YDXNT to inhibit microglia-mediated neuroinflammation as an instance. Methods: A multi-component random content-oriented chemical library of YDXNT was constructed by uniform design, and their chemical fingerprint was profiled by liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS) methods. Then the neuroinflammation activities of chemical library members of YDXNT were determined by image-based dual phenotypic quantification. Subsequently, fingerprint-efficacy correlation and random forest analysis were applied to predict the potentially active compounds with interactive effects. Finally, the interactive effects among the active compounds were confirmed by quantitative polymerase chain reaction (qPCR) and apoptosis analysis, and network pharmacology was applied to explore the possible mechanisms. Results: Image-based fingerprint-efficacy correlation analysis revealed that six tanshinones (TNs) and four flavonoids (FAs) were potential anti-neuroinflammatory compounds. The inter-family of TNs and FAs possessed obvious interactive effects (combination index <= 0.825). Moreover, the combination of scutellarein and tanshinone I (2:1, w/w) was discovered as the possible interactive combinatorial components, which, comparing with individual scutellarein or tanshinone I, shown more powerful effects on anti-inflammatory and antiapoptotic effects in lipopolysaccharide (LPS)-induced BV2 cells. Network pharmacology showed that the active compounds might suppress microglia-mediated neuroinflammation via multiple targets in the T cell receptor, Jak-STAT, and Toll-like receptor signaling pathways. Conclusion: The image-based fingerprint-efficacy strategy simplifies the screening process of efficacious component combinations in CMs for complex diseases, which also offers a promising approach to explore the integrative therapeutic mechanisms of CMs.

Identification Of Nuclear Factor-Kappa B Inhibitors And Beta(2) Adrenergic Receptor Agonists In Chinese Medicinal Preparation Fuzilizhong Pills Using Uplc With Quadrupole Time-Of-Flight Ms

Identification of nuclear factor-κB inhibitors and β2 adrenergic receptor agonists in Chinese medicinal preparation Fuzilizhong pills using UPLC with quadrupole time-of-flight MS

Bioactivity-integrated Ultra-Performance Liquid Chromatography/quadrupole Time-of-flight Mass Spectrometry for the Identification of Nuclear Factor-Κb Inhibitors and Β2 Adrenergic Receptor Agonists in Chinese Medicinal Preparation Chuanbeipipa Dropping Pills.

Comprehensive Profiling of Lingzhihuang Capsule by Liquid Chromatography Coupled with Mass Spectrometry-Based Molecular Networking and Target Prediction

Rapid Identification of Anti-Inflammatory Compounds from Tongmai Yangxin Pills by Liquid Chromatography with High-Resolution Mass Spectrometry and Chemometric Analysis

Dual-bioactivity-based liquid chromatography-coupled quadrupole time-of-flight mass spectrometry for NF-κB inhibitors and β 2 AR agonists identification in Chinese Medicinal Preparation Qingfei Xiaoyan Wan

Microfractionation Bioactivity-Based Ultra Performance Liquid Chromatography/quadrupole Time-of-flight Mass Spectrometry for the Identification of Nuclear Factor-Κb Inhibitors and Β2 Adrenergic Receptor Agonists in an Alkaloidal Extract of the Folk Herb Alstonia Scholaris

Ultra-high-performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry coupled with three-step data post-processing techniques for comprehensive profiling of the multiple components in Fufang Xianzhuli Ye

Identification and Comparative Analysis of the Major Chemical Constituents in the Extracts of Single Fuzi Herb and Fuzi-Gancao Herb-Pair by UFLC-IT-TOF/MS.

Identification and Quantitation of NF-κB Inhibitory Components in Weichang'an Pill Based on UHPLC-QE-MS and Spectrum-Effect Relationship

Identification of NF-κB inhibitors in Qishenyiqi dropping pills for myocardial infarction treatment based on bioactivity-integrated UPLC-Q/TOF MS.

Detection, Characterization and Identification of Major Constituents in Zhimu-Baihe Herb-Pair Extract by Fast High-Performance Liquid Chromatography and Time-of-flight Mass Spectrometry Through Dynamic Adjustment of Fragmentor Voltage.

Filtration and qualification for target biomarkers of traditional Chinese medicine formula "fuzi lizhong decoction" acting on stomach ulcer by UPLC/Q-TOF MS

Library-based UHPLC-Q-exactive-orbitrap-MS putative identification of isomeric and non-isomeric bioactives from Zibushengfa Tablet and pharmacopeia quality-marker chemistry

An Image-Based Fingerprint-Efficacy Screening Strategy for Uncovering Active Compounds with Interactive Effects in Yindan Xinnaotong Soft Capsule.

Comprehensive chemical profiling and quantitative analysis of ethnicYi medicine Miao-Fu-Zhi-Tong granules using UHPLC-MS/MS

Fingerprint Analysis of Zhimu-Huangbai Herb Pair and Simultaneous Determination of Its Alkaloids, Xanthone Glycosides and Steroidal Saponins by HPLC-DAD-ELSD

Comprehensive Chemical Profiling and Quantitative Analysis of Eth-Nic Yi Medicine Miao-Fu-Zhi-Tong Granules Using UHPLC-MS/MS

Rapid identification of chemical constituents in traditional Chinese medicine fufang preparation xianling gubao capsule by LC-linear ion trap/Orbitrap mass spectrometry.

Bioactivity-based Liquid Chromatography-Coupled Electrospray Ionization Tandem Ion Trap/time of Flight Mass Spectrometry for Β2ar Agonist Identification in Alkaloidal Extract of Alstonia Scholaris

<i>Aconitum</i> Diterpenoid Alkaloid Profiling to Distinguish between the Official Traditional Chinese Medicine (TCM) Fuzi and Adulterant Species Using LC-qToF-MS with Chemometrics